TCF21/POD-1, a Transcritional Regulator of SF-1/NR5A1, as a Potential Prognosis Marker in Adult and Pediatric Adrenocortical Tumors

With recent progress in understanding the pathogenesis of adrenocortical tumors (ACTs), identification of molecular markers to predict their prognosis has become possible. Transcription factor 21 (TCF21)/podocyte-expressed 1 (POD1) is a transcriptional regulatory protein expressed in mesenchymal cel...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Front Endocrinol (Lausanne)
Autores principales: Passaia, Barbara dos Santos, Dias, Matheus Henrique, Kremer, Jean Lucas, Antonini, Sonir Roberto Rauber, de Almeida, Madson Queiroz, Fragoso, Maria Candida Barisson Villares, Lotfi, Claudimara Ferini Pacicco
Formato: Artigo
Lenguaje:Inglês
Publicado: Frontiers Media S.A. 2018
Materias:
Endocrinology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5827685/
https://ncbi.nlm.nih.gov/pubmed/29520253
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2018.00038
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares